tetano
Editor, Senior Moderator
BMJ Case Rep
. 2021 May 31;14(5):e242220.
doi: 10.1136/bcr-2021-242220.
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
Omar Fueyo-Rodriguez[SUP] 1 [/SUP], Benjamin Valente-Acosta[SUP] 2 [/SUP], Rodolfo Jimenez-Soto[SUP] 1 [/SUP], Yvette Neme-Yunes[SUP] 1 [/SUP], Sergio Ignacio Inclán-Alarcón[SUP] 1 [/SUP], Roxana Trejo-Gonzalez[SUP] 1 [/SUP], Miguel Ángel García-Salcido[SUP] 3 [/SUP]
Affiliations
Abstract
Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).
Keywords: COVID-19; immunological products and vaccines.
. 2021 May 31;14(5):e242220.
doi: 10.1136/bcr-2021-242220.
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
Omar Fueyo-Rodriguez[SUP] 1 [/SUP], Benjamin Valente-Acosta[SUP] 2 [/SUP], Rodolfo Jimenez-Soto[SUP] 1 [/SUP], Yvette Neme-Yunes[SUP] 1 [/SUP], Sergio Ignacio Inclán-Alarcón[SUP] 1 [/SUP], Roxana Trejo-Gonzalez[SUP] 1 [/SUP], Miguel Ángel García-Salcido[SUP] 3 [/SUP]
Affiliations
- PMID: 34059544
- DOI: 10.1136/bcr-2021-242220
Abstract
Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).
Keywords: COVID-19; immunological products and vaccines.